CONFERENCE UPDATE View All
NEWS & PERSPECTIVE View All
Features View All

Advancing the treatment in primary generalized tonic-clonic seizures: A novel time-to-event study of lacosamide

Primary generalized tonic-clonic seizure (PGTCS) is the most serious seizure type in idiopathic generalized epilepsy (IGE) and a known risk of sudden unexpected death in epilepsy (SUDEP).1 Co-occurring with typical absences and myoclonic seizures, PGTCS is experienced by 74% of IGE patients.2,3 Desp

06 Sep 2021
thumb

Professor Philippe Ryvlin  

Chair of the Department of Clinical Neurosciences,  
Lausanne University Hospital,  
Switzerland  

thumb

Professor Hideaki Shiraishi  

Lecturer,
Department of Pediatrics,
Hokkaido University Hospital
Vice Director,
Hokkaido University Hospital Epilepsy Center

thumb

Professor Terence O’Brien

Department of Neuroscience,  
Central Clinical School,  
Alfred Health and Monash University,  
Australia